Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Lancet · 2011 · PMC3243929 · PMID 22036019

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

weakly significantno p-value reported

CAPP1 revealed a weakly significant effect of aspirin on size of largest observed polyp and a significant reduction in crypt length in participants given resistant starch. 2 In CAPP2 over 6 years, 937 people from 43 international centres commenced intervention. 3 After intervention, mean 29 months, there was no evidence that either a

also in 1,387 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.